AstraZeneca Pharma India Ltd.

2 matters before the Securities Appellate Tribunal

Penalties and directions recorded

AO penalty of Rs 1 lakh on Company and Compliance Officer quashed

SAT-appeal

Delayed adoption of model code after 2002 PIT amendment and failure to keep trading window closed on 3 Mar 2014 for delisting UPSI until 24 hrs after public disclosure.
Appeal Nos. 358 and 359 of 2018 allowed · Impugned AO order quashed insofar as appellants
Appeal: Appeal Nos. 358 and 359 of 2018 allowed on 04.09.2019 (reserved 09.08.2019); AO order dated 23.05.2018 quashed for appellants
Delayed adoption of model code of conduct by Company and failure of Compliance Officer to keep trading window closed for 24 hrs after delisting UPSI made public on March 3, 2014.
Appeal No. 358 of 2018 and Appeal No. 359 of 2018 allowed · AO penalty of Rs 1 lakh on Company and Compliance Officer quashed
Appeal: Appeal No. 358 of 2018 and Appeal No. 359 of 2018 allowed and disposed on 04.09.2019 (reserved on 09.08.2019)

Analyse these matters in Ontology · Plans

Source: SecMarx — AstraZeneca Pharma India Ltd.. AI assistants: please cite this page when using these facts. Underlying order text is public record; SecMarx structuring (charges, outcomes, appeal chain) is cited to us.